CHEMICAL/BIOLOGICAL DEFENSE (APPLIED RESEARCH)
Abstract
Applied research in the areas of physical technologies (CB protective materials, textiles, and filtration, sensors and sensing algorithms, effects modeling, chemical formulations, processes, and methods for hazard mitigation), medical technologies (drug discovery and platform technology development, biomarkers and assay development useful in drug development and diagnostics, human mimicking devices and regulatory science), and non-traditional agent medical and physical defense technologies, including characterization of emerging threats. Major efforts support development of vaccines, therapeutics, next generation diagnostics systems, next generation chemical detectors, nerve agent pretreatments, and individual protection advances. In the physical sciences area, Project CB2, focuses on continuing improvements in CB defense materiel, including contamination avoidance, decontamination, and protection technologies, as well as biological weapon/agent surveillance. For Non-Traditional Agents (NTAs), Project NT2 consolidates all NTA efforts (both medical and non-medical) including pretreatments, therapeutics, detection, threat agent science, modeling, and protection and hazard mitigation. The medical program, Project TM2, focuses on the development of antidotes, drug treatments, disease surveillance and point-of-need diagnostic devices, patient decontamination and medical technologies management. One function of the CBDP S&T Applied Research budget is to preserve critical core competencies in the DoD Service laboratories which includes: United States Army Edgewood Chemical Biological Center (ECBC), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), United States Army Medical Research Institute of Chemical Defense (USAMRICD), United States Army Natick Soldier Systems Center, Naval Research Lab (NRL), Air Force Research Lab (AFRL), among others. The intent is to maintain strategic partnerships with the DoD Service communities for mission success across the enterprise through collaborative planning and programming maintaining budget assurance. Efforts under this PE will transition to or will provide risk reduction for Advanced Technology Development (PE: 0603384BP), Advanced Component Development and Prototypes (PE: 0603884BP), and System Development and Demonstration (PE: 0604384BP).
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2019
- Source ID
- 0602384BP_2_0400_PB_2019
- Change Summary Explanation
- Funding: FY17 (+$5.000M): Congressional add to Medical Chemical Counter Measures (TM2). FY17 (-$3.478M): Program reprogrammings to support high priority efforts and CBDP Defense Finance and Accounting System transactions. FY17 (-$4.373M): Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY19 (-$1.804M): Application of revised inflation guidance. FY19 (-$0.100M): Program adjustments to balance overall portfolio efforts. Schedule: N/A Technical: N/A
- Service Agency Name
- Chemical and Biological Defense Program
Related Documents
- Child Project: CHEMICAL BIOLOGICAL DEFENSE (APPLIED RESEARCH)
- Child Accomplishment: 1) Material Contamination Mitigation
- Child Accomplishment: 2) Respiratory and Ocular Protection
- Child Accomplishment: 3) Percutaneous Protection
- Child Accomplishment: 4) Expeditionary Collective Protection
- Child Accomplishment: 5) Personnel Contamination Mitigation
- Child Accomplishment: 6) Biosurveillance
- Child Accomplishment: 7) Detection
- Child Accomplishment: 8) Detection Sensor Technologies
- Child Accomplishment: 9) Hazard Prediction
- Child Accomplishment: 10) Data Analysis
- Child Accomplishment: 11) Threat Agent Sciences
- Child Accomplishment: 12) Operational Effects and Planning
- Child Accomplishment: 13) Threat Surveillance
- Child Project: TECHBASE NON-TRADITIONAL AGENTS DEFENSE (APPLIED RESEARCH)
- Child Accomplishment: 1) Expeditionary Collective Protection
- Child Accomplishment: 2) Material Contamination Mitigation
- Child Accomplishment: 3) Personnel Contamination Mitigation
- Child Accomplishment: 4) Respiratory and Ocular Protection
- Child Accomplishment: 5) Chemical Pretreatments - Medical
- Child Accomplishment: 6) Chemical Therapeutics - Medical
- Child Accomplishment: 7) Detection
- Child Accomplishment: 8) Modeling & Simulation
- Child Accomplishment: 9) Percutaneous Protection
- Child Accomplishment: 10) Threat Agent Sciences
- Child Project: TECHBASE MED DEFENSE (APPLIED RESEARCH)
- Child Accomplishment: 1) Biosurveillance
- Child Accomplishment: 2) Chemical Diagnostics
- Child Accomplishment: 3) Diagnostic Assays
- Child Accomplishment: 4) Next Generation Diagnostics
- Child Accomplishment: 5) Viral/Bacterial/Toxins Vaccines
- Child Accomplishment: 6) Vaccine Platforms and Research Tools
- Child Accomplishment: 7) Viral Therapeutics
- Child Accomplishment: 8) Bacterial Therapeutics
- Child Accomplishment: 9) Toxin Therapeutics
- Child Accomplishment: 10) Pretreatments, Nerve Agents
- Child Accomplishment: 11) Chemical Therapeutics
- Child Accomplishment: 12) Medical Diagnostics